Read about Birth Control, Zika and more

"FDA Office of Women's Health" <fda@xxxxxxxxxxxxxxxxxxxxxxx> · Wed, 14 Sep 2016 14:58:10 -0500

Title:     Read about Birth Control, Zika and more

            September 2016
www.fda.gov/womens

            Message from the Director
OWH has remained at the forefront of issues through collaboration, research and surveillance. We are continuing to build on lessons learned from OWH-funded research projects and have developed new tools to help women and their families. I encourage you to share the resources, safety alerts and announcements in this update with your networks, friends and family. 
Marsha Henderson, Assistant Commissioner for Women’s Health

           Women's Health Highlights

           New Women’s Health Toolkits: Help Spread the Word

OWH has released several partner
toolkits that can be used to help connect diverse women with FDA’s resources. Each
kit includes sample social media messages, blog posts and other outreach tools.
Use our new toolkits to encourage the women in your community to take time for
their health. 
Hispanic Women's Health Toolkit
Diverse
     Women in Clinical Trials Toolkit
College
     Women’s Toolkit

New Article on Women and Zolpidem (Ambien)

A new article in Frontiers in Pharmacology highlights
OWH-supported research at the National Institutes of Health to further
knowledge about how sleep medicines affect women. The research explores whether sex differences in zolpidem pharmacokinetics are influenced by known sex-related variability in the _expression_ of alcohol and aldehyde dehydrogenases in rats

Read the article
Learn more about OWH-supported research
Download and Share a Fact Sheet on Sleep Medicines

           New FDA Birth Control Chart

OWH has released an updated version of our Birth Control Chart. The easy-to-read chart provides information on the safety and effectiveness of FDA-approved medicines and devices for birth control. The chart also provides information on emergency contraception. 
Download the FDA Birth Control Chart in English or Spanish

Safety Alert on Screening Tests for Ovarian Cancer 

Despite extensive research and published studies, there are currently no screening tests for ovarian cancer that are sensitive enough to reliably screen for ovarian cancer without a high number of inaccurate results. However, over the years, numerous companies have marketed tests that claim to screen for and detect ovarian cancer. 

The FDA is alerting women about the risks associated with the use of tests being marketed as ovarian cancer screening tests. The Agency is especially concerned about delaying effective preventive treatments for women who show no symptoms, but who are still at increased risk for developing ovarian cancer. Based on currently available information, the FDA recommends against using currently offered tests to screen for ovarian cancer.
Read
the safety communication

                              Extras

           Fraudulent Zika Products
Beware of fraudulent products claiming
to prevent or treat Zika. There are no FDA-approved treatments for Zika virus.
There are no FDA-approved vaccines for Zika virus. Several investigational
vaccines are under development, including those in early human clinical trials. FDA is
monitoring for fraudulent products and false product claims related to Zika
virus. Consumers are encouraged to report the sale of illegal products marketed
to prevent, treat or cure the Zika virus.
Report false
claims about Zika products to FDA 

            FDA Meetings

National
Mammography Quality Assurance Advisory Committee Meeting  
September 15, 8:30 a.m. to
4:30 p.m. 
Gaithersburg Holiday Inn,
Gaithersburg, MD
General and
Plastic Surgery Devices Panel of the Medical Devices Advisory Committee 
September 20-21, 8:30 a.m.
to 4:30 p.m. 
Gaithersburg Holiday Inn,
Gaithersburg, MD
Antibody-Targeted
Cancer Immunotherapy, Georgetown University CERSI
September 20, 11:00 a.m.
to 12:00 p.m. 
Adobe Connect Webinar

OWH Conference Exhibits
National Indian Health Board, National Tribal Health
Conference – September 19-22, Scottsdale, AZ

American Academy of Family Physicians – September
20-24, Orlando, FL

      Please share this update with your network, members, constituents, and community

FDA Office of Women's Health
10903 New Hampshire Avenue
WO32 - Room 2333
Silver Spring, MD 20993*0002
301-796-9440

Subscriber Services: 
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)